{
  "meta": {
    "title": "33_Myelodysplastic_Syndrome_Myeloproliferative_Syndromes_And_Histiocytosis",
    "url": "https://brainandscalpel.vercel.app/33-myelodysplastic-syndrome-myeloproliferative-syndromes-and-histiocytosis-c3586181.html",
    "scrapedAt": "2025-11-30T12:33:37.457Z"
  },
  "questions": [
    {
      "text": "A 73-year-old woman presents with chronic fatigue and easy bruising. She has had surgery for ovarian cancer 7 years ago along with chemoradiation. Her lab reports reveal pancytopenia and bone marrow biopsy shows the following finding. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Aplastic anemia"
        },
        {
          "id": 2,
          "text": "Myelodysplastic syndrome"
        },
        {
          "id": 3,
          "text": "Acute lymphoblastic leukemia"
        },
        {
          "id": 4,
          "text": "Myelophthisic anemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong>&nbsp;</strong>given clinical scenario is suggestive of <strong>therapy-related myelodysplastic syndrome</strong> (t-MDS).</p>\n<p>The bone marrow biopsy stained with Perl's Prussian blue shows <strong>ringed sideroblasts.&nbsp;</strong>They are<strong>&nbsp;</strong>erythroblasts with <strong>iron-laden mitochondria</strong> visible as perinuclear granules as shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/346ee94f46484e2283e80f30c925710fx798x599.JPEG\" alt=\"Explanation Image\"><p>Myelodysplastic syndrome is&nbsp;a group of&nbsp;<strong>clonal stem cell disorders</strong>&nbsp;characterized by&nbsp;<strong>maturation defects,&nbsp;</strong>associated with ineffective hematopoiesis.</p>\n<p>It is of two&nbsp;<strong>types</strong>:</p>\n<ul>\n<li>Primary MDS - develops slowly, usually after 50 years of age.</li>\n<li>Secondary or therapy-related MDS (t-MDS) -<strong>&nbsp;</strong>develops 2 to 8 years after toxic drug or radiation exposure with poor prognosis</li>\n</ul>\n<p>Patients usually present with weakness, infections and hemorrhages due to pancytopenia. Both types of MDS have a high risk of&nbsp;<strong>transformation</strong>&nbsp;to acute myeloid leukemia&nbsp;(<strong>AML</strong>). However, most frequent and rapid transformation occurs in&nbsp;<strong>therapy-related MDS</strong>&nbsp;(t-MDS).</p><p>VEXAS syndrome&nbsp;(vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a Novel disorder discovered in 2020. It is an adult-onset inflammatory disease with clinical features that bridge rheumatologic &amp; hematologic conditions.&nbsp;VEXAS may be a prototype for new class of &ldquo;hematoinflammatory diseases.&rdquo; These diseases would be defined by somatic mutations in hematopoietic cells, systemic inflammation, &amp; potential to evolve into overt myelodysplastic, myeloproliferative, or lymphoproliferative disease.&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a25775b4073c4f32abbddcd1957a1ad2.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0240",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common cytogenetic change in children with myelodysplastic syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "5q deletion"
        },
        {
          "id": 2,
          "text": "Monosomy 5"
        },
        {
          "id": 3,
          "text": "7q deletion"
        },
        {
          "id": 4,
          "text": "Monosomy 7"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Monosomy 7 </strong>is the most common cytogenetic change&nbsp;seen in myelodysplastic syndrome (MDS) in<strong> children.</strong></p>\n<p><strong>5q deletion </strong>is the most common cytogenetic change seen in MDS in <strong>adults</strong>.</p>\n<p>The del(5q) abnormality is the dominant clone in most cases of MDS. This involves the stem-cell compartment and hence occurs as an early or initiating event in disease pathogenesis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5944",
      "difficulty": "medium"
    },
    {
      "text": "Which of these histopathological findings would you not expect to see in patients with myelodysplastic syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Ringed sideroblast"
        },
        {
          "id": 2,
          "text": "Pawn-ball megakaryocyte"
        },
        {
          "id": 3,
          "text": "Dohle bodies"
        },
        {
          "id": 4,
          "text": "Pelger-Huet cells"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Pseudo&ndash;Pelger&ndash;Huet cells</strong> are seen in <strong>myelodysplastic syndrome</strong> (MDS)<strong>&nbsp;</strong>and not Pelger<strong>&ndash;</strong>Huet cells.</p>\n<p>Pelger&ndash;Huet cells are seen in<strong> Pelger&ndash;Huet syndrome</strong>, which is due to mutations in the <strong>lamin B-receptor</strong><strong> gene.</strong> It is a&nbsp;neutrophil differentiation disorder with leukocyte appearance as:</p>\n<ul>\n<li><strong>Dumbbell-shaped bilobed</strong> nuclei</li>\n<li>Reduced number of nuclear segments</li>\n<li>Coarse clumping of the nuclear chromatin</li>\n</ul>\n<p>In <strong>MDS</strong>, pseudo-Pelger Huet cells are seen due to <strong>abnormal nuclear budding</strong> i.e. neutrophils with only 2 nuclear lobes.</p><hr><h3>Related Pearl: Bone Marrow Changes in Myelodysplastic Syndrome (MDS)</h3><p>The myelodysplastic syndrome can lead to dysplasia of the erythroid series, myeloid series, and megakaryocytes.</p>\n<p>Dysplasia of erythroid series:</p>\n<ul>\n<li><strong>Megaloblastoid maturation&nbsp;</strong>- Abnormally large erythroid cells</li>\n<li><strong>Nuclear budding abnormalities&nbsp;</strong>- Nucleus with abnormal shape</li>\n<li><strong>Ring sideroblasts&nbsp;</strong>- Erythroblasts with stainable iron in the cytoplasm&nbsp;</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5a79f916cf5b46d2a1ad0f781dddef8dx798x599.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Dysplasia of myeloid series:</p>\n<ul>\n<li>Neutrophils with a decreased number of secondary granules</li>\n<li class=\"p1\"><strong>Pseudo-Pelger-Hüet cells</strong>- neutrophils with only <strong>two nuclear lobes</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8fff2b32c6624e1da540ca3d292db163x359x512.JPEG\" alt=\"Pearl Image\"><p class=\"p1\">&nbsp;</p>\n<p class=\"p1\">Dysplasia of the megakaryocytes:</p>\n<ul>\n<li class=\"p1\">Megakaryocyte with single nuclear lobe</li>\n<li class=\"p1\"><strong>Pawn ball megakaryocytes</strong>- cells with multiple separate nuclei</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bc059ad7c9c0487cad202d46105ccdafx512x465.PNG\" alt=\"Pearl Image\"><p>If only one lineage is affected, then it is called single lineage dysplasia. If multiple lineages are affected, then it is called multilineage dysplasia. If the percentage of ring sideroblasts is more than 15% it is called MDS with ring sideroblasts (MDS-RS).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5943",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following bone marrow and peripheral blood findings is not seen in patients with myelodysplastic syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Image 1"
        },
        {
          "id": 2,
          "text": "Image 2"
        },
        {
          "id": 3,
          "text": "Image 3"
        },
        {
          "id": 4,
          "text": "Image 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Image 3 showing hypocellular bone marrow is not seen in <strong>myelodysplastic syndrome</strong> (MDS.) In this condition, bone marrow is<strong>&nbsp;hypercellular.</strong>&nbsp;However, <strong>pancytopenia</strong> results from ineffective hematopoiesis.</p>\n<p>The image given below shows the histopathological findings seen in MDS.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d9304056c604d0da59e14bf27ad3dd1x1280x1545.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4b596660e31f4986aca23ef3a02ba206.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5945",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man presents with complaints of fatigue, weight loss, and heaviness in the left hypochondrium for 6 months. His hemogram and peripheral smear are given below. What is the most likely diagnosis?<div class='question-desc-html'><p>Hb - 10 gm/dL</p>\n<p>TLC - 5.5 lakhs/mm3</p>\n<p>Platelet count - 4 lakhs/mm3</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Chronic lymphocytic leukemia"
        },
        {
          "id": 2,
          "text": "Chronic myeloid leukemia"
        },
        {
          "id": 3,
          "text": "Acute lymphoblastic leukemia"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>chronic myelogenous leukemia </strong>(CML).&nbsp;</p>\n<p>In this condition, the&nbsp;<strong>peripheral smear</strong>&nbsp;contains&nbsp;<strong>neutrophils</strong>&nbsp;and their&nbsp;<strong>precursors</strong>&nbsp;of&nbsp;<strong>various sizes</strong>&nbsp;and configurations like band cells, myelocytes, metamyelocytes,&nbsp;and blasts. Hence, the histological picture is described to have <strong>garden party </strong>or<strong>&nbsp;college girl</strong> appearance.<strong>&nbsp;</strong></p>\n<p>The image given below shows the peripheral smear in CML showing garden party or college girl appearance.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a1e04758334842edbcaa3e45942ffc6dx1280x1117.JPEG\" alt=\"Explanation Image\"><p>CML is a myeloproliferative disorder with peak incidence in the 5th to 6th decades of life. It occurs due to the&nbsp;chimeric BCR-ABL&nbsp;gene.</p>\n<p><strong>Clinical features</strong> of CML:</p>\n<ul>\n<li>Hypermetabolism</li>\n<li>Fatigability</li>\n<li>Weakness</li>\n<li>Weight loss and anorexia</li>\n<li>Extensive extramedullary hematopoiesis causing -\n<ul>\n<li>Splenomegaly</li>\n<li>Mild hepatomegaly</li>\n<li>Lymphadenopathy</li>\n</ul>\n</li>\n</ul>\n<p><strong>Hematological findings</strong> include:</p>\n<ul>\n<li>Mild-to-moderate anemia&nbsp;</li>\n<li>Leukocytosis</li>\n<li>Platelets - usually increased</li>\n<li>DLC shows&nbsp;predominantly neutrophils, band forms, metamyelocytes, myelocytes, eosinophils, and basophils and blasts (&gt;10%)&nbsp;</li>\n</ul>\n<p>Note:&nbsp;Convent girl appearance is seen in CLL.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8d5eaf70693448a29859e5222aafaa7a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5947",
      "difficulty": "easy"
    },
    {
      "text": "What mutation results in Philadelphia chromosome?",
      "choices": [
        {
          "id": 1,
          "text": "t(9;22)(q11;q34)"
        },
        {
          "id": 2,
          "text": "t(22;9)(q11;q34)"
        },
        {
          "id": 3,
          "text": "t(22;9)(q34;q11)"
        },
        {
          "id": 4,
          "text": "t(9;22)(q34;q11)"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 635\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Philadelphia chromosome</strong>&nbsp;results from&nbsp;<strong>t(9;22)(q34;q11</strong>). It is most commonly seen in chronic myeloid leukemia (<strong>CML</strong>)<strong>.</strong></p>\n<p>CML is due to the formation of a chimeric <strong>BCR-&shy;ABL </strong>gene or Philadelphia chromosome. This gene is derived from a <strong>reciprocal</strong>&nbsp;<strong>translocation&nbsp;</strong>(9;22)(q34;q11).&nbsp;</p>\n<p>The image given below shows the formation of the Philadelphia chromosome.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59e76b8423e64e0d9c3ded3140dd6b99x1280x2541.JPEG\" alt=\"Explanation Image\"><p>This translocation can be identified on fluorescence in situ hybridisation (FISH).</p>\n<p>The image given below shows<strong>&nbsp;</strong>(9;22) translocation as seen on FISH.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/75b99376f9834259a64754975241eae7x604x598.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0244",
      "difficulty": "hard"
    },
    {
      "text": "Bone marrow biopsy in a patient shows pseudo-Gaucher cells. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Primary myelofibrosis"
        },
        {
          "id": 2,
          "text": "Chronic myeloid leukemia"
        },
        {
          "id": 3,
          "text": "Essential thrombocythemia"
        },
        {
          "id": 4,
          "text": "Chronic Lymphocytic leukemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Psuedo-Gaucher</strong> cells are characteristic of chronic myeloid leukemia (<strong>CML</strong>).&nbsp; These cells&nbsp;are scattered macrophages with abundant wrinkled, green-blue cytoplasm. Their presence indicates a good prognosis.</p>\n<p><strong>Bone marrow </strong>findings in <strong>CML: </strong></p>\n<ul>\n<li>Markedly hypercellular marrow - increased&nbsp;maturing granulocytic precursors</li>\n<li>Elevated eosinophils and basophils</li>\n<li>Increased megakaryocytes - include small, dysplastic forms</li>\n<li>Erythroid progenitors - normal or mildly decreased</li>\n<li>Increased reticulin deposition</li>\n<li>Overt marrow fibrosis - rare early in the course</li>\n<li>Pseudo-Gaucher cells&nbsp;</li>\n<li>Sea blue histiocytes</li>\n</ul>\n<p>The image given below shows pseudo-Gaucher cells in chronic myeloid leukemia (CML).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0d2d7dd368714ca6b08e3fd2fdf81551x436x356.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5948",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old woman with fever and splenomegaly was diagnosed to have chronic myeloid leukemia. She was started on imatinib therapy. After a few months of therapy, she had persistent progressive splenomegaly and fatigue. Which of the following will not be seen in this phase?",
      "choices": [
        {
          "id": 1,
          "text": ">20% blasts in blood or marrow"
        },
        {
          "id": 2,
          "text": "> 20% basophils in blood"
        },
        {
          "id": 3,
          "text": "Platelet count  of <100 × 10^9/L"
        },
        {
          "id": 4,
          "text": "WBC count >10 × 10^9/L"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In a patient with chronic myeloid leukemia (<strong>CML</strong>), progressive splenomegaly, not responsive to therapy is suggestive of an&nbsp;<strong>accelerated phase</strong>. In this phase, <strong>blasts</strong> are <strong>&lt;20%</strong> in blood or marrow.&nbsp;</p>\n<p><strong>Diagnosis</strong> of an accelerated phase of CML requires one of the following <strong>criteria:</strong></p>\n<ul>\n<li>Persistent or increasing WBC (&gt;10 &times; 10<sup>9</sup>/L), unresponsive to therapy</li>\n<li>Persistent or increasing splenomegaly, unresponsive to therapy</li>\n<li>Persistent thrombocytosis (&gt;1000 &times; 10<sup>9</sup>/L), unresponsive to therapy</li>\n<li>Persistent thrombocytopenia (&lt;100 &times; 10<sup>9</sup>/L) unrelated to therapy</li>\n<li>20% or more basophils in the peripheral blood</li>\n<li>10%-19% blasts&nbsp;in the peripheral blood or bone marrow</li>\n<li>Additional clonal chromosomal abnormalities in Ph<sup>+</sup> cells at diagnosis that include &ldquo;major route&rdquo; abnormalities (second Ph, trisomy 8, isochromosome 17q, trisomy 19), complex karyotype, or abnormalities of 3q26.2</li>\n<li>Any new clonal chromosomal abnormality in Ph<sup>+</sup> cells that occurs during therapy</li>\n</ul><p>While the accelerated phase was an aggressive form of CML, the benefit of tyrosine kinase inhibitors and disease monitoring has successfully led to the <strong>omission of the accelerated phase</strong> of <strong>CML</strong> as per the <strong>5th edition of the WHO&nbsp;classification of hematolymphoid tumors.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5949",
      "difficulty": "medium"
    },
    {
      "text": "What is the percentage of blast cells in the blast phase of CML?",
      "choices": [
        {
          "id": 1,
          "text": "<10%"
        },
        {
          "id": 2,
          "text": "10-15%"
        },
        {
          "id": 3,
          "text": ">20%"
        },
        {
          "id": 4,
          "text": "15-20%"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the <strong>blast phase</strong> of chronic myeloid leukemia, there are <strong>&gt;20% </strong>blasts in the bone marrow.</p>\n<p>The 3 <strong>phases</strong> of <strong>CML</strong> are:</p>\n<ol>\n<li><strong>Chronic</strong> phase is the most common presentation. It is characterized by:\n<ul>\n<li>Leukocytosis - bimodal distribution with higher proportions of mature segmented neutrophils and myelocytes</li>\n<li>Blast cells &lt;10%</li>\n<li>Increased basophils and eosinophils</li>\n<li>Monocytosis &lt;3%</li>\n</ul>\n</li>\n<li><strong>Accelerated</strong> phase occurs in 50% of the patients who present with increasing anemia, thrombocytopenia and splenomegaly. It is characterized by:\n<ul>\n<li>Blast count 10-19%</li>\n<li>Basophilia &gt;20%</li>\n</ul>\n</li>\n<li><strong>Blast</strong> phase in CML occurs in an average of 3 years after the diagnosis. It is characterized by:\n<ul>\n<li>Large foci or clusters of blasts on the bone marrow biopsy &gt;20%.</li>\n<li>Presence of extramedullary blastic infiltrates (e.g., myeloid sarcoma or chloroma)</li>\n</ul>\n</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5950",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not seen in a patient with Myelodysplastic/Myeloproliferative syndrome (MDS/MPN) with neutrophilia?",
      "choices": [
        {
          "id": 1,
          "text": "Philadelphia chromosome negative"
        },
        {
          "id": 2,
          "text": "Basophilia >10%"
        },
        {
          "id": 3,
          "text": "Blasts <20%"
        },
        {
          "id": 4,
          "text": "Neutrophil precursors >10%"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Myelodysplastic/Myeloproliferative syndrome (MDS/MPN) with neutrophilia (previously named as atypical chronic myeloid leukemia) shows minimal absolute <strong>basophilia</strong>, i.e., <strong>&lt;2%</strong> of total WBCs.</p>\n<p>Myelodysplastic/Myeloproliferative syndrome (MDS/MPN) with neutrophilia is a leukemic disorder having features of both myelodysplastic and myeloproliferative features at the time of diagnosis. It is classified under the <strong>WHO 5th edition (2022) MDS/MPN</strong> category.</p>\n<p><strong>Characteristics </strong>of myelodysplastic/myeloproliferative syndrome (MDS/MPN) with neutrophilia:</p>\n<ul>\n<li>Peripheral blood leukocytosis with an&nbsp;increased number of mature and immature neutrophils</li>\n<li>Prominent dysgranulopoiesis</li>\n<li><strong>Philadelphia chromosome-negative</strong></li>\n<li><strong>Neutrophil</strong> <strong>precursors</strong>&nbsp;(promyelocytes, myelocytes, metamyelocytes)<strong> &gt;10%</strong> of WBCs</li>\n<li>Minimal absolute <strong>basophilia &lt;2%</strong> of WBCs</li>\n<li>Absolute monocytosis &lt;10% of WBCs</li>\n<li>Hypercellular bone marrow</li>\n<li><strong>&lt;20% blasts</strong> in blood and bone marrow</li>\n<li>Thrombocytopenia</li>\n</ul>\n<p><strong>Differences</strong> between CML and myelodysplastic/myeloproliferative syndrome (MDS/MPN) with neutrophilia:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>CML</strong></td>\n<td>Myelodysplastic/Myeloproliferative syndrome (MDS/MPN) with neutrophilia</td>\n</tr>\n<tr>\n<td>BCR-ABL gene&nbsp;</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Basophilia</td>\n<td>Present</td>\n<td>&lt;2%</td>\n</tr>\n<tr>\n<td>\n<p>Myeloblasts in peripheral blood</p>\n<p>Myeloblasts in bone marrow</p>\n</td>\n<td>\n<p>&lt;2%</p>\n<p>&lt;5%</p>\n</td>\n<td>\n<p>&lt;20%</p>\n<p>&lt;20%</p>\n</td>\n</tr>\n<tr>\n<td>Granulocytic dysplasia</td>\n<td>Minimal/ absent</td>\n<td>Prominent</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0257",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following patients will have a decreased leukocyte alkaline phosphatase score?",
      "choices": [
        {
          "id": 1,
          "text": "A 65-year-old-man with garden party appearance on peripheral smear"
        },
        {
          "id": 2,
          "text": "A 50-year-old man with Reed Sternberg cells on LN biopsy"
        },
        {
          "id": 3,
          "text": "A 35-year-old woman with Hb level of 23 g/dL"
        },
        {
          "id": 4,
          "text": "A 43-year-old woman with smudge cells on peripheral smear"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Leukocyte alkaline phosphatase (<strong>LAP</strong>) score is <strong>decreased</strong> in chronic myeloid leukemia (<strong>CML</strong>) i.e. garden party appearance on peripheral smear.</p><hr><h3>Related Pearl: Leucocyte Alkaline Phosphatase Score</h3><p>Alkaline phosphatase activity is found predominantly in&nbsp;<strong>mature segmented neutrophils</strong>. LAP score is obtained by assessing the&nbsp;<strong>staining intensity</strong>&nbsp;in 100 consecutive neutrophils, with each neutrophil scored on a scale of 1&ndash;4.&nbsp;</p>\n<p><strong>Conditions</strong> that result in an <strong>increase</strong> in <strong>leukocytes</strong> in all stages of maturity will reflect a corresponding <strong>increase</strong> in <strong>LAP</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Elevated LAP score</strong></p>\n</td>\n<td>\n<p><strong>Decreased LAP score</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leukemoid reaction</p>\n</td>\n<td>\n<p>Chronic myeloid leukemia (CML)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pregnancy</p>\n</td>\n<td>\n<p>Paroxysmal nocturnal hemoglobinuria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia vera</p>\n</td>\n<td>\n<p>Sickle cell anemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple myeloma</p>\n</td>\n<td>\n<p>Hypophosphatasia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Obstructive jaundice</p>\n</td>\n<td>\n<p>Aplastic anemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hodgkin lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5953",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following does not cause relative polycythemia?",
      "choices": [
        {
          "id": 1,
          "text": "Dehydration"
        },
        {
          "id": 2,
          "text": "Dengue hemorrhagic fever"
        },
        {
          "id": 3,
          "text": "Gaisbock syndrome"
        },
        {
          "id": 4,
          "text": "High altitude"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>High altitude produces absolute polycythemia and not relative polycythemia.</p>\n<p><strong>Polycythemia</strong> denotes an abnormally high red cell count, usually with a corresponding increase in the hemoglobin level (&gt; 16 &plusmn;2 g/dL). It is <strong>2 types</strong>:</p>\n<ul>\n<li>Relative - hemoconcentration due to decreased plasma volume</li>\n<li>Absolute - increase in the total red cell mass</li>\n</ul>\n<p><strong>Causes</strong> of <strong>relative</strong> polycythemia include:</p>\n<ul>\n<li>Dehydration - deprivation of water, prolonged vomiting or diarrhea, excessive use of diuretics</li>\n<li>Gaisb&ouml;ck syndrome -&nbsp;stress polycythemia where affected individuals are usually hypertensive, obese, and anxious</li>\n</ul>\n<p><strong>Causes</strong> of <strong>absolute</strong> polycythemia include:</p>\n<ul>\n<li>Primary -&nbsp;intrinsic abnormality of hematopoietic precursors&nbsp;\n<ul>\n<li>Polycythemia vera</li>\n<li>Inherited erythropoietin receptor mutations</li>\n</ul>\n</li>\n<li>Secondary -&nbsp;red cell progenitors responding to increased levels of erythropoietin\n<ul>\n<li>Compensatory due to cyanotic heart and lung disease, high altitude</li>\n<li>Paraneoplastic erythropoietin secreting tumours</li>\n</ul>\n</li>\n</ul>\n<p>Note: In dengue hemorrhagic fever, increased vascular permeability causes plasma leakage and volume loss. Hence, relative polycythemia is seen.</p><hr><h3>Related Pearl: Comparison between Properties of Various Types of Polycythemia</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Plasma volume</td>\n<td>RBC Mass</td>\n<td>O<sub>2&nbsp;</sub>saturation</td>\n<td>EPO concentration</td>\n</tr>\n<tr>\n<td>\n<p>Relative</p>\n<p>polycythemia</p>\n</td>\n<td><strong>&nbsp; &nbsp; &darr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n<p>vera</p>\n</td>\n<td><strong>&nbsp; &nbsp; &uarr;</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>EPO- producing tumors</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n<p>(High altitude)</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EPO: Erythropoietin</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0253",
      "difficulty": "hard"
    },
    {
      "text": "A young boy from high altitude came with fever and weakness and had the following reports - Hemoglobin 17 g%, TLC is 21,000 with neutrophils 25, lymphocytes 30, eosinophils 5, myelocytes and metamyelocytes 40 in peripheral smear. Next step in the investigation should be:",
      "choices": [
        {
          "id": 1,
          "text": "Philadelphia chromosome"
        },
        {
          "id": 2,
          "text": "JAK mutation"
        },
        {
          "id": 3,
          "text": "Erythropoietin levels"
        },
        {
          "id": 4,
          "text": "Bone Marrow biopsy with reticulin stain"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>polycythemia</strong> (Hb&gt;16 g/dL). Hence, <strong>erythropoietin levels</strong> (EPO)&nbsp;are estimated next, to differentiate between <strong>primary</strong> or <strong>secondary</strong> polycythemia. Based on EPO levels:</p>\n<ul>\n<li>Primary polycythemia -&nbsp;normal/ decreased</li>\n<li>Secondary polycythemia&nbsp;- increased</li>\n</ul>\n<p>Options A and B: JAK 2 mutation and Philadelphia chromosome analysis is only done as a last resort.</p>\n<p>Option D: Bone marrow estimation with reticulin is done for myelofibrosis&nbsp;which can be seen in the spent/ late stage of the disease. However, peripheral smear findings are not suggestive of primary myelofibrosis. Leukoerythroblastic reaction with dacrocytes is seen in myelofibrosis.</p><hr><h3>Related Pearl: Comparison between Properties of Various Types of Polycythemia</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Plasma volume</td>\n<td>RBC Mass</td>\n<td>O<sub>2&nbsp;</sub>saturation</td>\n<td>EPO concentration</td>\n</tr>\n<tr>\n<td>\n<p>Relative</p>\n<p>polycythemia</p>\n</td>\n<td><strong>&nbsp; &nbsp; &darr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n<p>vera</p>\n</td>\n<td><strong>&nbsp; &nbsp; &uarr;</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>EPO- producing tumors</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n<p>(High altitude)</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EPO: Erythropoietin</p><hr><h3>Related Pearl: WHO Polycythemia Vera Criteria</h3><p><span><strong>Major criteria:</strong></span></p>\n<p>1. Hemoglobin <strong>&gt;16.5 g/dL</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hemoglobin <strong>&gt;16.0 g/dL</strong> in women&nbsp;</p>\n<p>Or</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;49%</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;48%</strong> in women&nbsp;</p>\n<p>2. Bone marrow biopsy showing <strong>hypercellularity</strong> with <strong>trilineage hyperplasia</strong>&nbsp;(panmyelosis) and prominent erythroid, granulocytic, and megakaryocytic proliferation with pleomorphic mature megakaryocytes in the bone marrow, and&nbsp;</p>\n<p>3. Presence of&nbsp;<strong>JAK2 exon 12</strong> mutation</p>\n<p><span><strong>Minor criterion:</strong></span></p>\n<p>Subnormal serum erythropoietin level</p>\n<p>Diagnosis of polycythemia vera requires meeting either all 3 major criteria&nbsp;or the first 2 major criteria along with the minor criterion</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9278",
      "difficulty": "medium"
    },
    {
      "text": "A 24-year-old woman who presented with aquagenic pruritis had a Hb level of 20 g/dL. Her lab investigations are given below. Which of the following is not seen in this condition?<div class='question-desc-html'><p>Hb - 19 g/dL</p>\n<p>Hematocrit - 52%</p>\n<p>S. erythropoietin - decreased</p>\n<p>JAK2 mutation - positive</p>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Acute meyloid leukemia"
        },
        {
          "id": 2,
          "text": "Budd-Chiari syndrome"
        },
        {
          "id": 3,
          "text": "Myelofibrosis"
        },
        {
          "id": 4,
          "text": "Hepatic failure"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive&nbsp;of <strong>polycythemia vera</strong>. Hepatic failure is not seen in this condition.</p>\n<p>Polycythemia vera is strongly associated with activating point <strong>mutations</strong> in the tyrosine kinase <strong>JAK2.</strong>&nbsp;In this condition, clonal erythrocytosis occurs autonomously i.e. independent of erythropoietin.</p>\n<p><strong>Clinical features</strong> of polycythemia vera:</p>\n<ul>\n<li>Headache</li>\n<li>Hypertension</li>\n<li>Dizziness</li>\n<li>Intense pruritis, <strong>aquagenic pruritis</strong></li>\n<li>Peptic ulcer</li>\n<li>Venous thrombosis - <strong>Budd-Chiari syndrome</strong> (hepatic vein thrombosis), bowel infarction, stroke, myocardial infarction</li>\n<li>Minor hemorrhages - epistaxis, gum bleeding</li>\n</ul>\n<p><strong>Laboratory findings</strong> in polycythemia vera:</p>\n<ul>\n<li>Panmyelosis - increased marrow production of red cells, granulocytes, and platelets</li>\n<li><strong>Low erythropoietin </strong></li>\n<li>Elevated hematocrit</li>\n<li>Hyperuricemia</li>\n</ul>\n<p><strong>Complications</strong> of polycythemia vera:</p>\n<ul>\n<li><strong>Myelofibrosis</strong> and extensive extramedullary hematopoiesis - spent /late phase</li>\n<li><strong>Acute myeloid leukemia</strong></li>\n</ul><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;The FDA has recently approved Rropeginterferon alfa-2b injection to treat adults with polycythemia vera. It is the first interferon therapy specifically approved for polycythemia vera. Rropeginterferon alfa-2b is a long-acting drug that patients take by injection under the skin once every two weeks.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:829,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:3,&quot;12&quot;:0}\">The FDA has recently approved Ropeginterferon alfa-2b injection to treat adults with polycythemia vera. It is the first interferon therapy specifically approved for polycythemia vera. Ropeginterferon alfa-2b is a long-acting drug that patients take by injection under the skin once every two weeks.</span></p><hr><h3>Related Pearl: WHO Polycythemia Vera Criteria</h3><p><span><strong>Major criteria:</strong></span></p>\n<p>1. Hemoglobin <strong>&gt;16.5 g/dL</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hemoglobin <strong>&gt;16.0 g/dL</strong> in women&nbsp;</p>\n<p>Or</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;49%</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;48%</strong> in women&nbsp;</p>\n<p>2. Bone marrow biopsy showing <strong>hypercellularity</strong> with <strong>trilineage hyperplasia</strong>&nbsp;(panmyelosis) and prominent erythroid, granulocytic, and megakaryocytic proliferation with pleomorphic mature megakaryocytes in the bone marrow, and&nbsp;</p>\n<p>3. Presence of&nbsp;<strong>JAK2 exon 12</strong> mutation</p>\n<p><span><strong>Minor criterion:</strong></span></p>\n<p>Subnormal serum erythropoietin level</p>\n<p>Diagnosis of polycythemia vera requires meeting either all 3 major criteria&nbsp;or the first 2 major criteria along with the minor criterion</p><hr><h3>Related Pearl: Comparison between Properties of Various Types of Polycythemia</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Plasma volume</td>\n<td>RBC Mass</td>\n<td>O<sub>2&nbsp;</sub>saturation</td>\n<td>EPO concentration</td>\n</tr>\n<tr>\n<td>\n<p>Relative</p>\n<p>polycythemia</p>\n</td>\n<td><strong>&nbsp; &nbsp; &darr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n<p>vera</p>\n</td>\n<td><strong>&nbsp; &nbsp; &uarr;</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>EPO- producing tumors</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n<p>(High altitude)</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EPO: Erythropoietin</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5955",
      "difficulty": "medium"
    },
    {
      "text": "A 63-year-old woman complains about throbbing pain over both palms. Her examination findings and lab reports are given below. What is the most likely diagnosis?<div class='question-desc-html'><p>Hb - 11 g/dL</p>\n<p>WBC - 9,000 /mm<sup>3</sup></p>\n<p>Platelet count - 7,00,000 /&mu;L</p>\n<p>Bone marrow biopsy - hypercellular with megakaryocytes and reticulin fibrils</p>\n<p>Philadelphia chromosome - absent</p>\n<p>MPL mutation - positive</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Polycythemia vera"
        },
        {
          "id": 2,
          "text": "Essential thrombocythemia"
        },
        {
          "id": 3,
          "text": "Myelofibrosis"
        },
        {
          "id": 4,
          "text": "Leukemoid reaction"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>essential&nbsp;thrombocythemia</strong> (ET). The image showing erythematous hands is suggestive of <strong>erythromelalgia</strong>.</p>\n<p>Essential thrombocythemia (essential thrombocytosis) is a myeloproliferative neoplasm. It is associated with mutations that increase JAK-STAT signaling.</p>\n<p><strong>WHO criteria</strong> for diagnosis of essential thrombocythemia:</p>\n<ul>\n<li>Major criteria -\n<ul>\n<li>Platelet count &ge;450 &times; 10<sup>9</sup>/L</li>\n<li>Bone marrow biopsy showing proliferation mainly of the megakaryocyte lineage with increased numbers of enlarged, mature megakaryocytes with hyperlobulated nuclei</li>\n<li>Not meeting WHO criteria for BCR-ABL1 chronic myeloid leukemia, PV, PMF, myelodysplastic syndromes, or other myeloid neoplasms</li>\n<li>Presence of JAK2, CALR, or MPL mutation</li>\n</ul>\n</li>\n<li>Minor criteria - the presence of a clonal marker or absence of evidence for reactive thrombocytosis</li>\n</ul>\n<p><strong>Diagnosis</strong> of ET requires meeting all <strong>4 major</strong> criteria <strong>or</strong> the first <strong>3 major</strong> criteria and the <strong>minor</strong> criterion</p>\n<p>Option A: Polycythemia vera can also present with erythromelalgia. However, it also presents with <strong>increased Hb</strong> levels.&nbsp;</p>\n<p>Option C: <strong>Fibrosis</strong> (not reticulin fibrils) is seen in bone marrow biopsy of primary myelofibrosis.&nbsp;</p>\n<p>Option D: <strong>WBC counts</strong> are <strong>increased</strong> in leukemoid reactions.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/68bf629723124f318c01b3ab2614be1d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5956",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following conditions do not have a leukoerythroblastic picture on peripheral smear?",
      "choices": [
        {
          "id": 1,
          "text": "Myelofibrosis"
        },
        {
          "id": 2,
          "text": "Myelophthisic anemia"
        },
        {
          "id": 3,
          "text": "Thalassemia"
        },
        {
          "id": 4,
          "text": "Gaucher disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Leukoerythroblastic picture is not seen in patients with thalassemia as it is a hemoglobinopathy and does not involve myeloid precursors.</p>\n<p>Abnormal presence of <strong>immature</strong> <strong>precursors</strong> of blood in the peripheral blood smear is called <strong>leukoerythroblastosis.&nbsp;</strong>Findings include:</p>\n<ul>\n<li>Nucleated red cells</li>\n<li>Dacryocytes (or teardrop RBC) - formed due to damage to red cell membrane caused by fibrous tissue in the marrow</li>\n<li>Immature cells of granulocytic series</li>\n</ul>\n<p>It occurs due to conditions causing <strong>marrow replacement</strong> like:</p>\n<ul>\n<li>Primary myelofibrosis - fibrosis of bone marrow</li>\n<li>Myelophthisic anemia - space occupying lesions of bone marrow</li>\n<li>Gauchers disease</li>\n<li>Spent phase of polycythemia vera</li>\n</ul>\n<p>&nbsp;The image given below shows a leukoerythroblastic blood picture with nucleated RBCs, tear-drop cells, and immature myeloid cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e1437ea4c10340708c6a4b076d29433cx1280x960.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5958",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not included under MDS/MPN overlap syndromes?",
      "choices": [
        {
          "id": 1,
          "text": "MDS/MPN with neutrophilia"
        },
        {
          "id": 2,
          "text": "Chronic myelomonocytic leukemia"
        },
        {
          "id": 3,
          "text": "MDS/MPN with SF31B mutation and thrombocytosis"
        },
        {
          "id": 4,
          "text": "MDS with excess blasts"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Myelodysplastic syndrome/ myeloproliferative neoplasm (<strong>MDS/MPN</strong>) <strong>overlap </strong>syndromes are a group of chronic clonal myeloid malignancies in which there are features of both MDS and MPN at the time of presentation. According to the 5th edition WHO classification (2022), it includes:</p>\n<ul>\n<li aria-level=\"1\">Chronic myelomonocytic leukemia</li>\n<li aria-level=\"1\">MDS/MPN with neutrophilia (previously atypical chronic myeloid leukemia)</li>\n<li aria-level=\"1\">MDS/MPN with SF31B mutation and thrombocytosis</li>\n<li aria-level=\"1\">MDS/MPN not otherwise specified</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0255",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not compatible with a diagnosis of chronic myelomonocytic leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "Peripheral blood monocytosis more than 1×10^9/L"
        },
        {
          "id": 2,
          "text": "Absence of Philadelphia chromosome"
        },
        {
          "id": 3,
          "text": "More than 20% blasts in blood or bone marrow"
        },
        {
          "id": 4,
          "text": "Absent or minimal dysplasia in myeloid lineages"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>More than 20% of blasts in the blood or bone marrow are not compatible with a diagnosis of chronic myelomonocytic leukemia (<strong>CMML</strong>). In this condition, <strong>blasts</strong> are <strong>less than 20%</strong>.</p>\n<p><strong>WHO 5th edition diagnostic criteria</strong>&nbsp;(2022_for chronic myelomonocytic leukemia (CMML) include:</p>\n<p><strong>Prerequisite criteria:</strong></p>\n<ul>\n<li aria-level=\"1\">1. Persistent absolute (<strong>&ge;0.5 &times; 10<sup>9</sup>/ L</strong>) and relative (<strong>&ge;10%</strong>) peripheral blood monocytosis.</li>\n<li aria-level=\"1\">2. Blasts constitute <strong>&lt;20%</strong> of the cells in the peripheral blood and bone marrow.</li>\n<li aria-level=\"1\">3. Not meeting diagnostic criteria of chronic myeloid leukemia or other myeloproliferative neoplasms (MPN).<sup>b</sup></li>\n<li aria-level=\"1\">4. Not meeting diagnostic criteria of myeloid/lymphoid neoplasms with tyrosine kinase fusions.<sup>c</sup></li>\n</ul>\n<p><strong>Supporting criteria:</strong></p>\n<ul>\n<li aria-level=\"1\">1. Dysplasia involving &ge;1 myeloid lineage.<sup>d</sup></li>\n<li aria-level=\"1\">2. Acquired clonal cytogenetic or molecular abnormality.</li>\n<li aria-level=\"1\">3. Abnormal partitioning of peripheral blood monocyte subsets.<sup>e</sup></li>\n</ul>\n<p><strong>Pre-requisite criteria must be present in all cases:</strong></p>\n<ul>\n<li aria-level=\"1\">If monocytosis is &ge; 1 &times; 10<sup>9</sup>/ L: one or more supporting criteria must be met.</li>\n<li aria-level=\"1\">If monocytosis is &ge;0.5 and &lt;1 &times; 10<sup>9</sup>/ L: supporting criteria 1 and 2 must be met.</li>\n</ul>\n<p><strong>Subtype criteria:</strong></p>\n<ul>\n<li aria-level=\"1\">Myelodysplastic CMML (MD-CMML): WBC &lt; 13 &times; 10<sup>9</sup>/L</li>\n<li aria-level=\"1\">Myeloproliferative CMML (MP-CMML): WBC &ge; 13 &times; 10<sup>9</sup>/L</li>\n</ul>\n<div class=\"page\" title=\"Page 7\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>a. Blasts and blast equivalents include myeloblasts, monoblasts, and promonocytes.</span><br /><span> b. MPN with monocytosis can mimic CMML. In these instances, a documented history of MPN excludes CMML. The presence of MPN features in the bone marrow and/or a high burden of MPN-associated mutations (JAK2, CALR, or MPL) tends to support MPN with monocytosis rather than CMML.</span></p>\n<p><span>c. Criteria for myeloid/lymphoid neoplasms with tyrosine kinase fusions should be specifically excluded in cases with eosinophilia.</span><br /><span> d. Morphologic dysplasia should be present in &ge;10% of cells of a hematopoietic lineage in the bone marrow.</span></p>\n<p><span>e. Based on the detection of increased classical monocytes (&gt;94%) in the absence of known active autoimmune diseases and/or systemic inflammatory syndromes.</span></p>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5959",
      "difficulty": "medium"
    },
    {
      "text": "A 2-year-old boy with Noonan syndrome presents with hepatosplenomegaly and lymphadenopathy. You are suspecting juvenile myelomonocytic leukemia. Which of the following is not seen in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "GM-CSF hypersensitivity"
        },
        {
          "id": 2,
          "text": "Absence of Philadelphia chromosome"
        },
        {
          "id": 3,
          "text": "Poor prognosis"
        },
        {
          "id": 4,
          "text": "Increased Hb A2 level"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>HbF</strong> levels are <strong>increased</strong> in <strong>juvenile myelomonocytic leukemia</strong> (JMML),&nbsp;not Hb A2.&nbsp;</p>\n<p>JMML is a hematopoietic stem cell-derived myeloproliferative neoplasm of early childhood. It is one of the myeloproliferative neoplasms. It is associated with mutations in the RAS pathway. Neurofibromatosis 1, Noonan syndrome, and trisomy 8 mosaicism can predispose to this condition.&nbsp;Aggressive types include PTPN11 mutation and neurofibromatosis type 1.</p>\n<p><strong>WHO diagnostic guidelines </strong>of JMML:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Category I (Mandatory):</strong></p>\n<p><strong>Clinical and hematologic features</strong></p>\n</td>\n<td>\n<p><strong>Category II: </strong></p>\n<p><strong>Genetic (only 1 required)</strong></p>\n</td>\n<td><strong>Category III: Category I + these findings:</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Splenomegaly</li>\n<li>Peripheral blood monocyte count &ge;1 &times; 10<sup>9</sup>/L</li>\n<li>Blast percentage in peripheral blood and bone marrow &lt;20%</li>\n<li>No Philadelphia chromosome (BCR/ABL1 rearrangement)</li>\n<li>Exclusion of KMT2A mutation</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Somatic mutation in&nbsp;<em>PTPN11</em>* or&nbsp;<em>KRAS</em>* or&nbsp;<em>NRAS</em>*</li>\n<li>Clinical diagnosis of Neurofibromatosis type 1 or NF1 mutation</li>\n<li>Germline CBL mutation</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\"1\">Hemoglobin F increased for age</li>\n<li aria-level=\"1\">Myeloid or erythroid precursors on the peripheral blood smear</li>\n<li aria-level=\"1\">Hypersensitivity to GM-CSF by colony assay and STAT5 hyperphosphorylation</li>\n<li aria-level=\"1\">Thrombocytopenia with hypercellular bone marrow</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Germline mutation (indicating Noonan syndrome) needs to be excluded.</p>\n<p>It is associated with a<strong> poor prognosis</strong> and only a few patients undergo spontaneous regression.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5951",
      "difficulty": "medium"
    },
    {
      "text": "JAK2 mutation is most commonly associated with _____",
      "choices": [
        {
          "id": 1,
          "text": "Polycythemia vera"
        },
        {
          "id": 2,
          "text": "Essential thrombocytosis"
        },
        {
          "id": 3,
          "text": "CML"
        },
        {
          "id": 4,
          "text": "PMF"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Polycythemia vera </strong>is strongly associated with activating point <strong>mutations</strong> in the tyrosine kinase<strong> JAK2</strong>.</p>\n<p>A mutation in JAK2, a key member of the cytokine intracellular signaling pathway, can be found in <strong>90&ndash;95%</strong> of patients with polycythemia vera.</p>\n<p>It is characterized by :</p>\n<ul>\n<li>Increased marrow production of red cells, granulocytes, and platelets&nbsp;<strong>(panmyelosis)</strong></li>\n<li><strong>Low&nbsp;</strong><strong>erythropoietin levels and elevated hematocrit</strong></li>\n<li>Blood viscosity and sludging lead to both thrombosis and bleeding.</li>\n<li>Headache, dizziness, hypertension, dizziness, venous thrombosis (Budd Chiari syndrome due to hepatic vein thrombosis), bowel infarction, and stroke.</li>\n<li><strong>Intense pruritus especially aquagenic pruritus</strong>&nbsp;</li>\n<li>Peptic ulceration, hyperuricemia</li>\n<li>15% to 20% of patients after an average period of 10 years -&gt;Myelofibrosis and extensive extramedullary hematopoiesis,</li>\n<li>PCV transforms into AML in 2% of patients.</li>\n</ul>\n<p><strong>Primary myelofibrosis</strong></p>\n<ul>\n<li>Marrow fibrosis associated with extramedullary hemopoiesis in the spleen.</li>\n<li><strong>Activating mutation in JAK2&nbsp;</strong><strong>(more commonly) or&nbsp;<em>MPL</em>.</strong></li>\n<li>Presence of neoplastic megakaryocytes, which are responsible for the release of fibrogenic factors like PDGF (platelet-derived growth factor) and TGF-&beta;.</li>\n<li>Bone&nbsp;<strong>marrow aspiration&nbsp;</strong><strong>yields dry tap&nbsp;</strong>due to fibrosis of the bone marrow.</li>\n<li>So,&nbsp;<strong>bone marrow biopsy is the investigation of choice</strong>, which shows the presence of hypocellularity with increased deposition of reticulin inside the marrow, abnormal megakaryocytes and the characteristic finding of dilated marrow sinusoids.</li>\n<li>Blood shows mild leukocytosis, decreased Hb and hematocrit levels, and elevated LAP scores.</li>\n<li>Acute myeloid leukemia (AML) occurs in 5% to 20% of cases.</li>\n</ul>\n<p><strong>Essential thrombocytosis (ET)</strong> may also be associated with&nbsp;<em>JAK2</em>,&nbsp;<em>MPL</em>, or&nbsp;<em>CALR</em>&nbsp;mutations.</p>\n<ul>\n<li>Essential thrombocytosis (ET) is often associated with activating point mutations in&nbsp;<strong><em>JAK2</em>&nbsp;(50% of cases) or&nbsp;<em>MPL</em>&nbsp;(5% to 10% of cases)</strong>, a receptor tyrosine kinase that is normally activated by thrombopoietin.</li>\n<li>In addition, recent DNA sequencing studies have revealed that most of the remaining cases have mutations in&nbsp;<strong>calreticulin (CALR)</strong>, a protein with several functions in the endoplasmic reticulum and the cytoplasm. Since&nbsp;<em>JAK2</em>&nbsp;and calreticulin mutations are mutually exclusive, it is hypothesized that the calreticulin mutations also increase JAK-STAT signaling through mechanisms that are currently unknown.</li>\n</ul>\n<p>CML is the consequence of the balanced translocation between chromosomes 9 and 22 (t[9;22]).</p>\n<p>PV, PMF, and ET are characterized by driver mutations that directly or indirectly constitutively activate JAK2, a tyrosine kinase essential for the function of the erythropoietin andthrombopoietin receptors and also utilized by granulocyte colony stimulating factor receptor.</p><hr><h3>Related Pearl: WHO Polycythemia Vera Criteria</h3><p><span><strong>Major criteria:</strong></span></p>\n<p>1. Hemoglobin <strong>&gt;16.5 g/dL</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hemoglobin <strong>&gt;16.0 g/dL</strong> in women&nbsp;</p>\n<p>Or</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;49%</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;48%</strong> in women&nbsp;</p>\n<p>2. Bone marrow biopsy showing <strong>hypercellularity</strong> with <strong>trilineage hyperplasia</strong>&nbsp;(panmyelosis) and prominent erythroid, granulocytic, and megakaryocytic proliferation with pleomorphic mature megakaryocytes in the bone marrow, and&nbsp;</p>\n<p>3. Presence of&nbsp;<strong>JAK2 exon 12</strong> mutation</p>\n<p><span><strong>Minor criterion:</strong></span></p>\n<p>Subnormal serum erythropoietin level</p>\n<p>Diagnosis of polycythemia vera requires meeting either all 3 major criteria&nbsp;or the first 2 major criteria along with the minor criterion</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6712",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following patients is least likely to have leukemoid reaction?",
      "choices": [
        {
          "id": 1,
          "text": "A patient with severe meningitis"
        },
        {
          "id": 2,
          "text": "A child with Down syndrome"
        },
        {
          "id": 3,
          "text": "A patient with hemorrhagic shock"
        },
        {
          "id": 4,
          "text": "A patient with acute myocardial infarction"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Myocardial infarction does not cause leukemoid reaction.</p>\n<p><strong>Leukemoid reaction </strong>is defined as <strong>persistent leukocytosis </strong>above 50000 cells /mm<sup>3</sup>,<sup>&nbsp;</sup>where the cause is other than leukemia.</p>\n<p><strong>Causes </strong>of leukemoid reaction include:</p>\n<ul>\n<li>Severe infections</li>\n<li>Malignancy</li>\n<li>Severe hemorrhage</li>\n<li>Acute hemolysis</li>\n<li>Trisomy 21 (Down syndrome)</li>\n<li>Asplenia</li>\n<li>Diabetic ketoacidosis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0258",
      "difficulty": "medium"
    },
    {
      "text": "Electron microscopic picture of which of the following conditions is shown below?",
      "choices": [
        {
          "id": 1,
          "text": "Bernard–Soulier syndrome"
        },
        {
          "id": 2,
          "text": "Mycosis fungoides"
        },
        {
          "id": 3,
          "text": "Glanzmann thrombasthenia"
        },
        {
          "id": 4,
          "text": "Langerhans cell histiocytosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given electron microscopy image shows <strong>tennis racket</strong> shaped <strong>Birbeck granules</strong>. These granules&nbsp;are characteristic of <strong>Langerhans cell histiocytosis. </strong></p>\n<p>These granules are pentalaminar tubules with dilated terminal ends. This gives a characteristic <strong>tennis racket</strong> appearance on electron microscopy. They contain the protein langerin (CD207).</p>\n<p>The image given below shows the Birbeck granules as seen on electron microscopy.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4dcf900614ef422d95f0a0eb2baa5943x1280x1589.JPEG\" alt=\"Explanation Image\"><p>On peripheral smear, the proliferating Langerhans cells are characterised by:</p>\n<ul>\n<li>Abundant vacuolated cytoplasm</li>\n<li>Vesicular nuclei containing linear grooves or&nbsp;folds -&nbsp;<strong>coffee bean nuclei</strong></li>\n</ul>\n<p>The image given below shows Langerhans cells with coffee bean nuclei and moderately abundant pale cytoplasm mixed with a few eosinophils.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3ab4f69596b042458b6695eb55c25bc4x1280x1078.JPEG\" alt=\"Explanation Image\"><p>Note: Tennis racket cells&nbsp;in light microscopy seen in sarcoma botryoides.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c284377481414961ab0bc7d4b46d52c1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0238",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a histiocytic neoplasm?",
      "choices": [
        {
          "id": 1,
          "text": "Langerhans cell histiocytosis"
        },
        {
          "id": 2,
          "text": "Rosai-Dorfman disease"
        },
        {
          "id": 3,
          "text": "Erdheim-Chester disease"
        },
        {
          "id": 4,
          "text": "Disseminated juvenile xanthogranuloma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Rosai&ndash;Dorfman disease is not a histiocytic neoplasm. It is sinus histiocytosis with massive lymphadenopathy.</p>\n<p>WHO classification of histiocytic/ hematolymphoid neoplasm 2016 includes the following:</p>\n<ul>\n<li>Histiocytic sarcoma</li>\n<li><strong>Langerhans cell histiocytosis</strong></li>\n<li>Langerhans cell sarcoma</li>\n<li>Indeterminate dendritic cell tumour</li>\n<li>lnterdigitating dendritic cell sarcoma</li>\n<li>Follicular dendritic cell sarcoma</li>\n<li>Fibroblastic reticular cell tumour</li>\n<li><strong>Disseminated juvenile xanthogranuloma</strong></li>\n<li><strong>Erdheim&ndash;Chester disease</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5967",
      "difficulty": "hard"
    },
    {
      "text": "You are suspecting Langerhans cell histiocytosis in a child with an enlarging scalp lesion. Which of the following markers will you test to confirm your diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "CD11a"
        },
        {
          "id": 2,
          "text": "HLA-DQ"
        },
        {
          "id": 3,
          "text": "CD107"
        },
        {
          "id": 4,
          "text": "S-100"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>S-100</strong> is a marker for <strong>Langerhans cell histiocytosis</strong>.</p>\n<p>Tumour cells in this condition typically express the following:</p>\n<ul>\n<li>HLA-DR</li>\n<li>S-100</li>\n<li>CD1a</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0216",
      "difficulty": "medium"
    },
    {
      "text": "A 5-year-old girl is brought to you by her father, who states that the girl is drinking a lot of water lately. Physical examination reveals exophthalmos. Further workup shows the presence of multiple lytic bone lesions involving her calvarium and the base of her skull.  What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Letterer-Siwe disease"
        },
        {
          "id": 2,
          "text": "Hand- Schuller- Christian disease"
        },
        {
          "id": 3,
          "text": "Eosionophilic granuloma"
        },
        {
          "id": 4,
          "text": "Unifocal Langerhans cell histiocytosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>Hand&ndash;Sch&uuml;ller&ndash;Christian disease. </strong></p>\n<p>Langerhans cell histiocytosis presents as multiple clinicopathological entities:</p>\n<p>1.&nbsp;<strong>Hand&ndash;Sch&uuml;ller&ndash;Christian </strong>disease&nbsp;is a multifocal unisystem&nbsp;Langerhans cell histiocytosis.&nbsp;It&nbsp;usually affects young children.&nbsp;It is characterized by the triad of:</p>\n<ul>\n<li>Diabetes insipidus (excessive thirst) -&nbsp;involvement of the posterior pituitary stalk of the hypothalamus</li>\n<li>Exophthalmos</li>\n<li>Multiple lytic bone lesions</li>\n</ul>\n<p>It usually undergoes spontaneous regression. It is treated with local excision or irradiation.</p>\n<p>2.<strong> Letterer&ndash;Siwe disease</strong> is a multifocal multisystem Langerhans cell histiocytosis. It occurs most frequently before 2 years of age, but occasionally affects adults.</p>\n<p>It is characterized by the following features:</p>\n<ul>\n<li>Cutaneous lesions, resembling a seborrheic eruption - caused by infiltrates of Langerhans cells over the front and back of the trunk and on the scalp</li>\n<li>Hepatosplenomegaly</li>\n<li>Lymphadenopathy</li>\n<li>Pulmonary lesions</li>\n<li>Destructive osteolytic bone lesions</li>\n<li>Due to marrow infiltration - anemia, thrombocytopenia, predisposition to recurrent infections (otitis media and mastoiditis)&nbsp;</li>\n</ul>\n<p>Treatment involves intensive chemotherapy. This condition is fatal if left untreated.</p>\n<p>3. <strong>Eosinophilic granuloma</strong> is a unifocal unisystem Langerhans cell histiocytosis. It is characterized by the proliferation of Langerhans cells admixed with variable numbers of eosinophils, lymphocytes, plasma cells, and neutrophils.&nbsp;</p>\n<p>These lesions occur in the following sites:</p>\n<ul>\n<li>Medullary cavities of bones - most commonly the calvarium, ribs, and femur</li>\n<li>Skin</li>\n<li>Lungs</li>\n<li>Stomach</li>\n</ul>\n<p>Bone lesions can manifest as:</p>\n<ul>\n<li>Asymptomatic</li>\n<li>Pain</li>\n<li>Tenderness</li>\n<li>Pathologic fractures.</li>\n</ul>\n<p>Treatment is by local excision or irradiation.</p>\n<p>&nbsp;</p>\n<p>4. <strong>Pulmonary</strong> Langerhans cell histiocytosis is most often seen in adult smokers. It regresses spontaneously upon cessation of smoking.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0237",
      "difficulty": "medium"
    },
    {
      "text": "The X-ray of a 65-year-old man is given below. Clinical examination, and hematological and urinary tests were normal. Which of the following is the probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Multiple myeloma"
        },
        {
          "id": 2,
          "text": "Langerhans cell histiocytosis"
        },
        {
          "id": 3,
          "text": "Metastasis"
        },
        {
          "id": 4,
          "text": "Hyperparathyroidism"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image showing a <strong>solitary</strong>&nbsp;<strong>punched-out lytic lesion</strong>&nbsp;without a sclerotic rim with&nbsp;a&nbsp;<strong>beveled</strong><strong>&nbsp;edge</strong>&nbsp;appearance, along with the age of the patient with history of <strong>normal</strong> hematological and urinary tests is suggestive of&nbsp;<strong>Langerhans cell histiocytosis.</strong></p>\n<p>Langerhans cell histiocytosis occurs due to the proliferation of a special type of immature dendritic cells, called&nbsp;Langerhans cells.&nbsp;Their&nbsp;normal function is to present antigens.</p>\n<p>It is characterized by&nbsp;<strong>single </strong>or<strong> multiple osteolytic bone lesions.&nbsp;</strong>It<strong>&nbsp;</strong>can also infiltrate the skin (of the scalp), lungs, liver, spleen, bone marrow, or the central nervous system.&nbsp;</p><hr><h3>Related Pearl: Skeletal and Radiological manifestation of  Langerhan’s Cell Histiocytosis</h3><p><strong>Skull:</strong></p>\n<p>Solitary or multiple punched out lytic lesion without sclerotic rim.<br />Double contour or beveled edge appearance may be seen due to asymmetrical involvement of the inner and outer table (hole within a hole sign).<br />Button sequestra representing residual bone.<br />Geographic skull.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/504d808c549645b0bcadbcefbb529c39x720x655.JPEG\" alt=\"Pearl Image\"><p><strong>Spine:</strong></p>\n<p><strong>Vertebra Plana</strong>:it is the most common cause of vertebra plana in children;mostly seen in the thoracic spine.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0469c0ef21f44d53aefb652fcca8f295x720x845.PNG\" alt=\"Pearl Image\"><p><strong>Mandible:</strong></p>\n<p>Irregular radiolucent areas mostly involving superficial alveolar bone.</p>\n<p><strong>Floating tooth</strong>: loss of lamina dura.</p>\n<p><strong>Long Bones:</strong></p>\n<ul>\n<li>Permeative and aggressive appearing lesions occur</li>\n<li>Mainly involves <strong>diaphysis</strong> or <strong>meta diaphysis</strong></li>\n<li>Endosteal scalloping, Periosteal reaction(in healing phase),cortical thinning,intracortical tunneling and associated soft tissue mass can be seen.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/fb3d2835a649456290292b0401eb3fc4.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7439",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not true regarding the procedure done using the instrument given in the image below?",
      "choices": [
        {
          "id": 1,
          "text": "Contraindicated if platelet count <40,000"
        },
        {
          "id": 2,
          "text": "Breath holding is required"
        },
        {
          "id": 3,
          "text": "Procedure can be done in both lateral & prone position"
        },
        {
          "id": 4,
          "text": "Diagnosing an infiltrative or granulomatous disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image shows a <strong>bone marrow biopsy needle.&nbsp;Thrombocytopenia </strong>is<strong> not </strong>in itself a<strong> contraindication </strong>for bone marrow biopsy.<strong>&nbsp;</strong>However, a platelet count &gt;20,000 is ensured for safety purposes.</p>\n<p><strong>Indications </strong>of bone marrow biopsy:</p>\n<ul>\n<li>Evaluation of unexplained anemia, leukopenia, thrombocytopenia, pancytopenia</li>\n<li>Evaluation of polycythemia, thrombocytosis, leukocytosis</li>\n<li>Diagnosis and staging of lymphoma or solid tumors</li>\n<li>Diagnosis and evaluation of plasma cell disorders and leukemias</li>\n<li>Evaluation of suspected infiltrative and storage diseases</li>\n<li>Evaluation of fever of unknown origin, suspected mycobacterial, fungal, or parasitic infections, or granulomatous diseases</li>\n</ul>\n<p><strong>Contraindications</strong> of bone marrow biopsy:</p>\n<ul>\n<li>Severe hemophilia</li>\n<li>Severe disseminated intravascular coagulopathy</li>\n<li>Severe bleeding disorders</li>\n</ul>\n<p><strong>Procedure</strong> for bone marrow biopsy:</p>\n<p>Prone or lateral position is chosen for the procedure. Posterior superior iliac spine is identified. After disinfection and local anaesthesia, the patient is asked to inhale slowly through the nose and exhale slowly through the mouth to relieve anxiety .The needle is inserted and rotated on its axis.</p>\n<p>On reaching the desired depth, the stylet is removed and needle is advanced. The needle is rotated in the opposite direction to loosen the specimen. It is then withdrawn using the same rotational movement.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/abc691ac348544e79127b6941c1c71e6x800x640.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9e1a29810adf4e8db425729998e4107e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0156",
      "difficulty": "medium"
    },
    {
      "text": "Blood examination shows pancytopenia, which can be correct?<div class='question-desc-html'><p>A.&nbsp;Megaloblastic anemia</p>\n<p>B.&nbsp;Hairy cell leukemia</p>\n<p>C. Hypocellular MDS</p>\n<p>D.&nbsp;APML</p>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "B, D"
        },
        {
          "id": 2,
          "text": "A, B, C"
        },
        {
          "id": 3,
          "text": "B, C,  D"
        },
        {
          "id": 4,
          "text": "A, B, D"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Megaloblastic anemia</strong> (hypocellular phase), <strong>hairy cell leukemia,</strong> and <strong>hypocellular MDS</strong>&nbsp;can show <strong>pancytopenia</strong>. Acute promyelocytic leukemia is not associated with pancytopenia.&nbsp;&nbsp;</p>\n<p>Causes of <strong>pancytopenia</strong> with <strong>hypocellular bone marrow:</strong></p>\n<ul>\n<li>Acquired aplastic anemia</li>\n<li>Hypocellular myelodysplastic syndrome</li>\n<li>Rare aleukemic leukemia</li>\n<li>Some acute lymphoid leukemia</li>\n<li>Rare lymphomas of bone marrow</li>\n<li>Copper deficiency</li>\n</ul>\n<p>Causes of <strong>pancytopenia</strong> with <strong>cellular&nbsp;bone&nbsp;marrow:</strong></p>\n<ul>\n<li class=\"p2\">Myelodysplastic syndromes</li>\n<li class=\"p2\">Systemic lupus erythematosus</li>\n<li class=\"p2\">Paroxysmal nocturnal hemoglobinuria (PNH)</li>\n<li class=\"p2\">Hypersplenism</li>\n<li class=\"p2\">B<span class=\"s1\">12</span>, folate deficiency, Copper deficiency</li>\n<li class=\"p2\">Myelofibrosis</li>\n<li class=\"p2\">Aleukemic leukemia</li>\n<li class=\"p2\">HIV,&nbsp;Brucellosis,&nbsp;Leishmaniasis,&nbsp;Tuberculosis Sepsis</li>\n<li class=\"p2\">Myelophthisis&nbsp;</li>\n<li class=\"p2\">Bone marrow lymphoma</li>\n<li class=\"p2\">Sarcoidosis</li>\n<li class=\"p2\">Hairy cell leukemia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6936",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions will have the least chances of a dry tap on bone marrow aspiration?",
      "choices": [
        {
          "id": 1,
          "text": "Hairy cell leukemia"
        },
        {
          "id": 2,
          "text": "Follicular lymphoma"
        },
        {
          "id": 3,
          "text": "AML M7"
        },
        {
          "id": 4,
          "text": "Myelodysplastic syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Follicular lymphoma</strong> is the least likely cause of a dry tap on bone marrow aspiration.</p>\n<p>Causes of <strong>dry tap</strong> are:</p>\n<ul>\n<li>Metastatic carcinoma infiltration </li>\n<li>Chronic myeloid leukemia </li>\n<li><strong>Myelofibrosis</strong> </li>\n<li><strong>Hairy cell leukemia</strong> </li>\n<li>Acute leukemia </li>\n<li>Hodgkin's lymphoma</li>\n<li><strong>AML- M7</strong></li>\n</ul>\n<p>Causes of <strong>pancytopenia with cellular marrow</strong> are:</p>\n<p>Primary disease of marrow-</p>\n<ul>\n<li>Myelodysplastic syndrome</li>\n<li>Paroxysmal nocturnal hemoglobinuria (PNH)</li>\n<li>Myelofibrosis</li>\n<li>Aleukemic leukemia</li>\n<li>Myelophthisis</li>\n<li>Bone marrow lymphoma</li>\n<li>Hairy cell leukemia</li>\n</ul>\n<p>Secondary to systemic disease-</p>\n<ul>\n<li>SLE, sarcoidosis</li>\n<li>B12, folate deficiency</li>\n<li>Copper deficiency</li>\n<li>Hypersplenism</li>\n<li>Alcohol</li>\n<li>HIV infection, TB</li>\n<li>Brucellosis, leishmaniasis </li>\n</ul>\n<p> </p>\n<p>Note: Although marrow is hypercellular in CML, MDS etc., extensive marrow fibrosis (rare) has been proposed to account for a dry tap on bone marrow biopsy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6715",
      "difficulty": "medium"
    }
  ]
}